| Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia MJ Manco-Johnson, TC Abshire, AD Shapiro, B Riske, MR Hacker, ... New England Journal of Medicine 357 (6), 535-544, 2007 | 2265 | 2007 |
| Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B JS Powell, KJ Pasi, MV Ragni, MC Ozelo, LA Valentino, JN Mahlangu, ... New England Journal of Medicine 369 (24), 2313-2323, 2013 | 379 | 2013 |
| A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management LA Valentino, V Mamonov, A Hellmann, DV Quon, A Chybicka, P Schroth, ... Journal of thrombosis and haemostasis 10 (3), 359-367, 2012 | 326 | 2012 |
| Blood‐induced joint disease: the pathophysiology of hemophilic arthropathy LA Valentino Journal of Thrombosis and Haemostasis 8 (9), 1895-1902, 2010 | 312 | 2010 |
| Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients AD Shapiro, MV Ragni, LA Valentino, NS Key, NC Josephson, JS Powell, ... Blood, The Journal of the American Society of Hematology 119 (3), 666-672, 2012 | 257 | 2012 |
| Physiopathology of haemophilic arthropathy F Lafeber, P Miossec, LA Valentino Haemophilia 14, 3-9, 2008 | 221 | 2008 |
| Low-dose tissue plasminogen activator thrombolysis in children M Wang, T Hays, V Balasa, R Bagatell, R Gruppo, EF Grabowski, ... Journal of pediatric hematology/oncology 25 (5), 379-386, 2003 | 180 | 2003 |
| Central venous access devices in haemophilia LA Valentino, B Ewenstein, RJ Navickis, MM Wilkes Haemophilia 10 (2), 134-146, 2004 | 174 | 2004 |
| Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene N Hakobyan, T Kazarian, AA Jabbar, KJ Jabbar, LA Valentino Blood 104 (7), 2060-2064, 2004 | 167 | 2004 |
| Shed tumor gangliosides and progression of human neuroblastoma L Valentino, T Moss, E Olson, HJ Wang, R Elashoff, S Ladisch | 165 | 1990 |
| Joint protection in haemophilia EC RODRIGUEZ‐MERCHAN, V Jimenez‐Yuste, JA Aznar, U Hedner, ... Haemophilia 17, 1-23, 2011 | 154 | 2011 |
| Hemophilia: in review B Zimmerman, LA Valentino Pediatr Rev 34 (7), 289-294, 2013 | 140 | 2013 |
| Consensus recommendations for use of central venous access devices in haemophilia BM Ewenstein, LA Valentino, JM Journeycake, MD Tarantino, AD Shapiro, ... Haemophilia 10 (5), 629-648, 2004 | 135 | 2004 |
| Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency LA Valentino, N Hakobyan, T Kazarian, KJ Jabbar, AA Jabbar Haemophilia 10 (3), 280-287, 2004 | 117 | 2004 |
| US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors LA Valentino, CL Kempton, R Kruse‐Jarres, P Mathew, SL Meeks, ... Haemophilia 21 (5), 559-567, 2015 | 115 | 2015 |
| c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide FQ Wen, AA Jabbar, YX Chen, T Kazarian, DA Patel, LA Valentino Blood, The Journal of the American Society of Hematology 100 (3), 912-916, 2002 | 107 | 2002 |
| Experimental haemophilic arthropathy in a mouse model of a massive haemarthrosis: gross, radiological and histological changes N Hakobyan, C Enockson, AA Cole, DR Sumner, LA Valentino Haemophilia 14 (4), 804-809, 2008 | 104 | 2008 |
| Reformulated BeneFix®: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B T Lambert, M Recht, LA Valentino, JS Powell, C Udata, ST Sullivan, ... Haemophilia 13 (3), 233-243, 2007 | 103 | 2007 |
| Pathogenesis of haemophilic synovitis: experimental studies on blood‐induced joint damage LA Valentino, N Hakobyan, N Rodriguez, WK Hoots Haemophilia 13, 10-13, 2007 | 101 | 2007 |
| Secondary prophylaxis therapy: what are the benefits, limitations and unknowns? LA Valentino Haemophilia 10 (2), 147-157, 2004 | 101 | 2004 |
